Alexandria — 2017 Investments
3 investments dated 2017 · listed companies and verified rows first · show all
BiotechCambridge, US
Christoph M. Adams(Executive Officer, Director)James McArthur(Executive Officer)
BoardDavid Mott(Director)Mette Kirstine Agger(Director)Barbara Dalton(Director)Sandip Agarwala(Director)
Co-investorsLongitude CapitalNew Enterprise Associates (NEA)Pfizer Venture Investments
Clinical-stage genetic medicines company using human-derived AAV vectors and nuclease-free gene editing for rare diseases.
BiotechBedford, US
Siyamak Rasty(Executive Officer)Albert Seymour(Executive Officer)
BoardSteven Gillis(Director)Arthur Tzianabos(Executive Officer, Director)Kush Parmar(Director)inRichard Gregory(Director)
Co-investors5AM VenturesARCH Venture PartnersOUP (Osage University Partners)Deerfield Management CompanyHBM Healthcare InvestmentsMaverick Ventures+4 more
BiotechSeattle, US
Sanford Markowitz(Director)Thong Le(Executive Officer, Director, Promoter)David Schubert(Executive Officer, Promoter)James Sullivan(Director)Lindsay Rayle(Executive Officer, Promoter)Tadataka Yamada(Director)
Co-investorsCWRU Technology VenturesARCH Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.